ADMP News and Press, Adamis Pharmaceuticals Corporation From 08/04/21

Adamis Pharmaceuticals Corp (ADMP -2.8%) is selling a significant portion of its subsidiary, US Compounding, for up to $15M before fees and expenses. The payment will be made to Adamis in monthly installments over a year based on a multiple of gross revenue generated by the assets during the ...

SAN DIEGO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it has entered into a definitive agreement to sell a significant portion of the assets of its subsidiary, US Compounding Inc. (USC), related to USC’s human compound...

Based on Results Provided by the Inspector of Election, Stockholders Re-Elected All Five Members of the Company's Board of Directors Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis” or the “Company”) today announced that based on th...

7 Biotech Penny Stocks to Watch in Summer 2021 With Summer well underway, biotech penny stocks are heating up. Although the pandemic was responsible for the major biotech rally we witnessed last year, now, investors seem to be focused on these penny stocks regardless of their involv...

Top Reddit Penny Stocks For Your Watchlist Right Now Over the past year, finding penny stocks on Reddit has become a favored pastime for small-caps investors. While it can be challenging with hundreds of penny stocks to choose from, doing research will help to separate the winners f...

Top Robinhood Penny Stocks to Watch in 2021 Making a penny stocks watchlist is the best way to get ahead in the market. It offers a game plan, and a way to keep the top penny stocks for your list in an organized and concise fashion. However, many investors fail to take this simple s...

Adamis Pharmaceuticals is preparing to launch a Phase II/III study with TEMPOL in COVID-19 patients. The NIH recently reported that they found TEMPOL inhibits viral replication. I believe TEMPOL could be a leading COVID-19 therapeutic that can be employed at all stages of the infectio...

loops7/E+ via Getty Images Adamis Pharmaceuticals (ADMP) has begun activities to support the start-up of a clinical trial for Tempol, its COVID-19 drug. These activities include site identification and initiation, data base production, vendor management, and the establishment of an independen...

SAN DIEGO, June 11, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that clinical trial start-up activities are underway for examining the effects of Tempol, which is the Company’s experimental drug, in the treatment of COVID-19. Adamis ...

Gainers: Aethlon Medical AEMD +425%, Checkpoint Therapeutics CKPT +26%, Adamis Pharmaceuticals ADMP +12%, SCWorx (WORX) +18%, ZIOPHARM Oncology ZIOP +15%.Losers: Atossa Therapeutics ATOS -14%, CEL-SCI CVM -11%, Precipio (PR...